Cough syrup row: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma drugs
Rajasthan halted distribution of 19 Kayson Pharma medicines after at least three child deaths linked to contaminated cough syrup; over 10,000 samples tested with 42 failing quality standards, officials said.
- On Oct 3, the Rajasthan government suspended State Drug Controller Rajaram Sharma and halted Kaysons Pharma distribution after reports linked a cough syrup to at least 11 child deaths in Madhya Pradesh and Rajasthan.
- Health officials say the syrup contained dextromethorphan hydrobromide and was distributed under the Chief Minister's Free Medicine Scheme, with affected children losing consciousness shortly after treatment on September 16.
- Records show Kaysons Pharma has a history of quality failures, with over 10,000 samples tested since 2012, 42 failed, and batches KL-25/147 and KL-25/148 sent to the state drug testing laboratory.
- As a precaution, the state banned all 19 medicines from Kaysons Pharma, halted 22 batches, recalled about 1.33 lakh bottles, froze stock, formed an expert committee and served a show-cause memo to the manufacturer.
- Officials say new rules will mandate warning labels for children and pregnant women and stricter controls on respiratory drugs, while experts question government tendering and free-medicine oversight.
19 Articles
19 Articles
Cough Syrup Row: Rajasthan Govt Suspends Drug Controller; Kaysons Pharma's Distribution Halted
The Drug Controller General of India clarified that cough syrups containing the ingredient should only be prescribed to children above five years old and must never be given to those below two years.
Rajasthan Bans Distribution of All 19 Medicines Produced by Kaysons Pharma, Drug Controller Suspended
Get latest articles and stories on India at LatestLY. Following multiple child deaths and illnesses linked to its cough syrup, the Rajasthan government has banned the distribution of all 19 medicines produced by Jaipur-based Kaysons Pharma. Additionally, the state has suspended its Drug Controller, Rajaram Sharma, for allegedly influencing determinations of drug quality standards. India News | Rajasthan Bans Distribution of All 19 Medicines Prod…
Rajasthan suspends drug controller, cracks down on key cough syrup supplier
The Rajasthan government has halted 19 medicines from Kayson Pharma, the key supplier of the cough syrup allegedly linked to children's deaths in the state. Meanwhile, Tamil Nadu has also banned a particular cough syrup following cases in Madhya Pradesh and Rajasthan.


Rajasthan bans distribution of all 19 medicines produced by Kaysons Pharma, drug controller suspended
Following multiple child deaths and illnesses linked to its cough syrup, the Rajasthan government has banned the distribution of all 19 medicines produced by Jaipur-based Kaysons Pharma. Additionally, the state has suspended its Drug Controller, Rajaram Sharma, for allegedly influencing determinations of drug quality standards.
Cough syrup deaths: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma medicines
Cough syrup deaths: The state govt has reaffirmed its earlier advisory, while the Drug Controller General of India clarified on Friday that cough syrup should typically be administered only to children over five years old, and must never be given to those younger than two under any circumstances.
Coverage Details
Bias Distribution
- 78% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium